These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 4563704)
1. [Figure drawing test in Parkinsonic patients treated with L-dopa]. Puca FM; Megna GF; Barbieri NF; Di Perri R Acta Neurol (Napoli); 1972; 27(4):395-402. PubMed ID: 4563704 [No Abstract] [Full Text] [Related]
2. [The Rey complex picture test in evaluation of some effects induced by treatment with L-dopa in patients with parkinsonism]. Megna GF; Puca FM; Micalizzi V; Leggiadro N; Di Rosa AE Acta Neurol (Napoli); 1971; 26(4):473-83. PubMed ID: 4943712 [No Abstract] [Full Text] [Related]
3. [Toulouse-Piéron test in patients with Parkinsonism treated with L-dopa]. Megna GF; Puca FM; Leggiadro N; Micalizzi V; Pigneri MT Acta Neurol (Napoli); 1973; 28(2):213-22. PubMed ID: 4575429 [No Abstract] [Full Text] [Related]
4. [Experiences in the treatment of Parkinsonism with L-dopa. 3. Laboratory findings in patients treated with L-dopa]. Bergamini L; Bonzanino A; Bignolio F; Fabiani A; Fariello R; Mombelli AM; Mutani R; Pisani W; Postir A; Riccio A; Sabbatini F; Sandigliano G; Schiffer D Riv Patol Nerv Ment; 1970 Feb; 91(1):10-6. PubMed ID: 5524931 [No Abstract] [Full Text] [Related]
5. [Efficacy and side effects of L-dopa in patients with Parkinson's syndrome]. Lombardo L Arch Invest Med (Mex); 1973; 4(3):215-24. PubMed ID: 4784173 [No Abstract] [Full Text] [Related]
6. [Treatment of Parkinson's disease with L-dopa and with a combination of L-dopa and dopa-decarboxylase inhibitor]. Agnoli A; Casacchia M; Reitano M; Ruggieri S; Barba C; Zamponi A Minerva Med; 1972 Dec; 63(89):4853-61. PubMed ID: 4566743 [No Abstract] [Full Text] [Related]
7. [Utility of L-dopa in the treatment of Parkinson's disease and parkinsonism-like diseases]. Herskovits E; Matera R; Gacitua EF Medicina (B Aires); 1972; 32(1):10-4. PubMed ID: 5019629 [No Abstract] [Full Text] [Related]
8. [Treatment of Parkinsonic syndrome with levo-Dopa. Case reports]. Rosati G; Agnetti V; Mura F; Granieri E Minerva Med; 1974 May; 65(33):1811-23. PubMed ID: 4602058 [No Abstract] [Full Text] [Related]
9. Intellectual and memory function in parkinsonian and non-parkinsonian patients treated with L-dopa. Donnelly EF; Chase TN Dis Nerv Syst; 1973 Feb; 34(2):119-23. PubMed ID: 4706860 [No Abstract] [Full Text] [Related]
10. [Analysis of the effects of L-dopa during a 3-month course of treatment]. Pinto F; Venturini E Riv Neurobiol; 1970; 16(4):415-28. PubMed ID: 4949926 [No Abstract] [Full Text] [Related]
11. [Study of 30 parkinsonian patients treated for 6 months with L-Dopa]. Barbizet J; Duizabo P Therapie; 1972; 27(1):133-40. PubMed ID: 5017549 [No Abstract] [Full Text] [Related]
12. L-dopa in Parkinson's disease. A report on 95 cases and review of the literature. Lewis I J Med Assoc State Ala; 1971 May; 40(11):709-18. PubMed ID: 5573008 [No Abstract] [Full Text] [Related]
13. Preliminary observations on L-dopa in the treatment of Parkinson's disease. Jelsma F; Roth R; Ross P; Davis J J Ky Med Assoc; 1971 Apr; 69(4):265-9. PubMed ID: 5577419 [No Abstract] [Full Text] [Related]
14. [Attempt at treating parkinsonism with L-dopa and Artane]. Stelmasiak Z; Lackowska H; Maksymowicz B Pol Tyg Lek; 1971 Aug; 26(34):1325-6. PubMed ID: 5110789 [No Abstract] [Full Text] [Related]
15. [The Rorschach test in parkinsonian patients. Its course during treatment with L dopa. Its prognostic value]. Sevilla M; Vernet JP; Becle J; Darcourt G Ann Med Psychol (Paris); 1973 May; 1(5):577-608. PubMed ID: 4761931 [No Abstract] [Full Text] [Related]
16. [Psychologic evaluation of amantadine treatment of parkinsonism and comparative analysis of the effects with L-dopa]. Puca FM; Micalizzi V; Megna GF; Barbieri NF; Pigneri MT Acta Neurol (Napoli); 1971; 26(6):707-30. PubMed ID: 4946491 [No Abstract] [Full Text] [Related]
17. L-dopa in the treatment of Parkinsonism. Brezný I; Buranová D; Cernácek J; Trávniková M Act Nerv Super (Praha); 1972; 14(2):96. PubMed ID: 5040182 [No Abstract] [Full Text] [Related]
18. Evaluation of L-dopa therapy in Parkinson's disease. Mones RJ; Elizan TS; Siegel GJ N Y State J Med; 1970 Sep; 70(18):2309-18. PubMed ID: 5272106 [No Abstract] [Full Text] [Related]
19. A hort-term evaluation of L-dopa therapy in 34 patients with parkinsonism. Mones RJ; Elizan TS J Mt Sinai Hosp N Y; 1969; 36(6):503-15. PubMed ID: 5261089 [No Abstract] [Full Text] [Related]
20. [Silent period in patients with Parkinson's disease treated with L-Dopa]. Palao Sánchez A Arch Neurobiol (Madr); 1973; 36(1):47-56. PubMed ID: 4706780 [No Abstract] [Full Text] [Related] [Next] [New Search]